[Effect of treatment with nucleoside analogues in subjects with primary genotypic resistance to zidovudine].
Leal
M
M
Caruz
A
A
Rey
C
C
Lissen
E
E
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D016049:Didanosine / Q000008:administration & dosage*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005838:Genotype; D015497:HIV-1 / Q000235:genetics; D006801:Humans; D016047:Zalcitabine / Q000008:administration & dosage*; D015215:Zidovudine / Q000008:administration & dosage*
D019380:Anti-HIV Agents; D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine
Efecto del tratamiento con análogos de nucleósidos en sujetos con resistencia genotípica primaria a zidovudina.